Largest genetic study of inflammatory bowel disease provides clues on new drug targets

In two studies published today (Jan. 30) in Nature Genetics, researchers from the Wellcome Trust Sanger Institute and their collaborators have identified a genetic variant that doubles an individual's risk of developing ulcerative colitis, one of the subtypes of a chronic disorder known as Inflammatory Bowel Disease (IBD).

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Jan [+]    Nature Genetics [+]    Wellcome Trust Sanger Institute [+]    Inflammatory Bowel Disease [+]    IBD [+]   

More #news: